American Express heads into the final days of April with options traders betting bullishly even as the stock softens — a notable divergence following last week's disappointing earnings reaction.
Options positioning is the standout signal this week. The put/call ratio has dropped to 0.46, nearly two standard deviations below its 20-day average of 0.51 and close to the lowest level of the past year (52-week low: 0.43). That's an unusually low reading — call buyers are running well ahead of put buyers, which is striking given the stock fell 5.7% the day after Q1 results on April 23 and has shed 4.2% on the week to close at $315.90. Options traders appear to be leaning into the pullback rather than hedging against further downside.
Short interest tells a more nuanced story. At 2.4% of free float — up sharply from 2.0% on April 24 — it has ticked to a one-month high following the post-earnings dip. The 33% build in estimated short interest over the past month is notable in absolute terms, though the level itself remains modest. Borrow is cheap at 0.47% annually, and availability in the lending pool is wide, meaning there's no squeeze pressure. Short sellers are incrementally more active, but not in a way that signals conviction — this looks more like opportunistic positioning around a known catalyst than a structural short thesis building.
The Street remains broadly constructive, even after marking down targets following tariff turbulence in early April. Goldman Sachs raised its target to $400 (from $360) while reiterating Buy on April 28 — one of the more bullish updates in the cohort. Bank of America lifted to $387, also Buy. These contrast with Barclays, which held an Equal-Weight stance and trimmed its target by a dollar to $322, and BTIG, which kept a Sell with a $285 target. The mean analyst target at $362 implies roughly 15% upside from current levels. Evercore ISI, having slashed its target from $393 to $330 in early April, has already reversed course and raised to $345. The dominant analyst direction is higher targets post-earnings, though the rating split — meaningful Buy versus stubborn Neutral/Sell camps — reflects genuine disagreement about the durability of AXP's growth.
The bull-bear debate centres on two competing narratives. Bulls point to new card account growth in Consumer and Commercial segments as a buffer against slower same-customer spending, and to the continued expansion of fee-paying cardholders as evidence of strong brand demand. Bears flag the sequential and year-over-year decline in new card acquisitions, arguing the Platinum Card refresh may be masking a deceleration in underlying billed business growth. The concern is that revenue expansion in the 5-8% range without the product refresh would look considerably less impressive. Capital market headwinds, including private credit valuation pressure, add another layer of uncertainty for AXP's super-prime consumer spending trends. The stock's EPS surprise factor score ranks in the 72nd percentile, suggesting a track record of beating estimates — though that record took a knock with the market's April 23 reaction. The dividend score at the 96th percentile underlines the quality tilt of the holder base.
Berkshire Hathaway's 22.2% anchor stake remains the most consequential ownership fact, unchanged in the latest filing. Among active managers, Capital Research added 2.46 million shares in the March quarter and FMR (Fidelity) added 1.43 million — the two most significant buyer additions across the top holders list. JP Morgan Asset Management also added 610,000 shares. These moves predate the earnings release, so whether that enthusiasm holds will become clearer in the next round of 13F filings.
The next scheduled event is May 5 — watch whether the options skew continues to narrow toward the 52-week low in PCR, or whether put demand returns as the stock consolidates around the $315-$322 zone that now sits at or just above the Barclays fair-value estimate.
See the live data behind this article on ORTEX.
Open AXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
